Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Anticancer gene vaccine inhibits human papillomavirus oncoprotein
March 16th, 2006
According to recent research from South Korea, an anticancer gene vaccine inhibits human papillomavirus oncoprotein. "Adeno-associated virus (AAV) Rep 78 protein is known to inhibit the promoter site of several oncogenes and viral genes, including the human papillomavirus (HPV) type 16 E6 transforming genes." "The biochemical studies of Rep 78 have been reported, but the effects of Rep 78 gene-mediated inhibition of HPV 16 E6 promoter activity on the various human cervical carcinoma cells have not been characterized," wrote W.S. Ahn and colleagues, Catholic University of Korea. "pEGFP-N1 vector, cloned by AAV-mediated Rep 78, is...
Source: Women's Health Weekly (2006-03-16)
|
